55.27
price down icon0.18%   -0.10
after-market Handel nachbörslich: 54.94 -0.33 -0.60%
loading

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
09:15 AM

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - BioSpace

09:15 AM
pulisher
08:06 AM

TG Therapeutics (TGTX) Reports Five-Year Study Showing BRIUMVI's - GuruFocus

08:06 AM
pulisher
07:13 AM

High Growth Tech Stocks To Watch In US October 2026 - Simply Wall Street

07:13 AM
pulisher
Oct 09, 2026

How TG’s MS Data Wave At MSToronto2026 At TG Therapeutics (TGTX) Has Changed Its Investment Story - Yahoo Finance

Oct 09, 2026
pulisher
Oct 08, 2026

TG Therapeutics (TGTX) to Present Phase 1 Azer-cel Data and BRIU - GuruFocus

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - Business Wire

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 08, 2026
pulisher
Oct 06, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Singapore

Oct 06, 2026
pulisher
Oct 05, 2026

TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech - ChartMill

Oct 05, 2026
pulisher
Oct 05, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 05, 2026
pulisher
Oct 02, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia

Oct 02, 2026
pulisher
Oct 01, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 01, 2026
pulisher
Sep 30, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia

Sep 30, 2026
pulisher
Sep 29, 2026

After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView

Sep 29, 2026
pulisher
Sep 29, 2026

TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView

Sep 29, 2026
pulisher
Sep 28, 2026

Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar

Sep 28, 2026
pulisher
Sep 28, 2026

TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 28, 2026
pulisher
Sep 23, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 21, 2026

TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill

Sep 21, 2026
pulisher
Sep 21, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Sep 21, 2026
pulisher
Sep 19, 2026

TG Therapeutics Inc (TGTX) Stock Price Today: $56.87 - Pluang

Sep 19, 2026
pulisher
Sep 18, 2026

TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - benzinga.com

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - Yahoo Finance

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance

Sep 18, 2026
pulisher
Sep 11, 2026

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

Sep 11, 2026
pulisher
Sep 10, 2026

TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference | TGTX Stock News - quiverquant.com

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - TG Therapeutics

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

Sep 10, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com India

Sep 09, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com UK

Sep 09, 2026
pulisher
Sep 09, 2026

TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView

Sep 09, 2026
pulisher
Sep 07, 2026

TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress

Sep 07, 2026
pulisher
Sep 07, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Sep 07, 2026
pulisher
Sep 04, 2026

TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits

Sep 04, 2026
pulisher
Sep 03, 2026

TG Therapeutics to Participate in the Cantor Global Healthcare Conference - manilatimes.net

Sep 03, 2026
pulisher
Sep 03, 2026

TG Therapeutics to Participate in the Cantor Global Healthcare Conference - TG Therapeutics

Sep 03, 2026
pulisher
Sep 03, 2026

TG Therapeutics to Participate in the Cantor Global Healthcare Conference - GlobeNewswire

Sep 03, 2026
pulisher
Sep 03, 2026

B. Riley Securities Remains a Buy on TG Therapeutics (TGTX) - The Globe and Mail

Sep 03, 2026
pulisher
Sep 03, 2026

(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Sep 03, 2026
pulisher
Sep 02, 2026

IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily

Sep 02, 2026
pulisher
Sep 02, 2026

TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Sep 02, 2026
pulisher
Sep 02, 2026

B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo

Sep 02, 2026
pulisher
Sep 01, 2026

TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $78 - GuruFocus

Sep 01, 2026
pulisher
Sep 01, 2026

H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78 - Moomoo

Sep 01, 2026
pulisher
Aug 31, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors - DirectorsTalk Interviews

Aug 31, 2026
CAI CAI
$29.69
price down icon 0.03%
$60.73
price down icon 3.22%
$166.00
price down icon 1.40%
$62.79
price down icon 0.19%
$85.90
price up icon 0.25%
$112.08
price down icon 0.28%
Kapitalisierung:     |  Volumen (24h):